Handelsavisen
prelaunch
Companies Healthcare FORA.O
FO
FORA.O NASDAQ Advanced Medical Equipment & Technology

Forian Inc.

$2,15
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
63,4M USD
P/E
EV / Rev
Div yield
Op margin
-12,4 %
ROE
-9,7 %
Net margin
-9,5 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
$2,15
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Forian Inc. provides healthcare equipment and technology solutions, primarily serving the medical industry.

Business. Forian Inc. (NASDAQ: FORA.O) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
HOLD1 analysts
0 buy1 hold0 sell
Avg 12m price target2,10

Analyst recommendations

1 analysts · consensus Hold
Buy0
Hold1
Sell0
12-month price target
2,10
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
1 analysts · indicative
Ownership
Geode Capital Management, L.L.C.
largest disclosed fund holder
Profitability
-9,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning FORA.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to FORA.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Forian Inc. (NASDAQ: FORA.O) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    Forian Inc. has a market capitalization of $63.42 million and a price-to-book ratio of 2.13, indicating a premium valuation relative to its book value. The company's liquidity position is strong, with a current ratio of 2.97, suggesting it can comfortably meet its short-term obligations. However, the company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure.

    The company's profitability metrics are concerning, with a negative return on equity of -9.65% and a return on assets of -6.51%, both significantly below industry norms. Operating income was -$3.76 million, and net income was -$2.87 million, reflecting ongoing operational challenges. Gross profit of $16.10 million was insufficient to offset operating expenses, contributing to the net loss.

    Forian Inc. generates revenue from its healthcare equipment and technology solutions, though the financial data does not provide a breakdown of revenue by segment or geographic region. The company's revenue for the latest period was $30.26 million, but the outlook for future growth is not specified in the available data.

    The company's free cash flow was negative at -$2.67 million, indicating that it is not generating sufficient cash from operations to fund its capital expenditures and other obligations. Analysts have assigned a mean price target of $2.10, which is slightly below the current market price of $2.15, suggesting a neutral outlook. The mean recommendation of 3.00 (on a scale from 1 to 5) further supports a neutral stance, with no strong buy or buy ratings.

    There are no immediate filing-based liquidity or dilution flags, and the risk assessment indicates low liquidity and dilution risks. The company's capital structure is currently free of dilution pressures, with no near-term dilution expected. The absence of long-term debt and the strong current ratio suggest that the company is in a stable financial position.

    Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's operating cash flow of $2.89 million provides some cushion, but it is not enough to offset the negative free cash flow. The company's total assets of $44.13 million and total equity of $29.78 million suggest a solid asset base, but the negative returns on equity and assets highlight the need for operational improvements.

    Key takeaways
    • Forian Inc. has a strong liquidity position with a current ratio of 2.97 and no long-term debt.
    • The company is currently unprofitable, with a negative return on equity of -9.65% and a net loss of $2.87 million.
    • Analysts have a neutral outlook, with a mean price target of $2.10 and a mean recommendation of 3.00.
    • The company's free cash flow is negative at -$2.67 million, indicating cash flow challenges.
    • There are no immediate liquidity or dilution risks, and the company's capital structure is conservative.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $2,15
    Market cap
    $63.4M
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    2.1x
    P / Tangible book
    2.1x
    Tangible book
    $29.8M
    Net cash
    Current ratio
    3.0
    Debt / equity
    0.0
    ROA
    -6.5%
    ROE
    -9.7%
    Cash conversion
    -100.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,09
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-16 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,09
    Revenueno estimateno estimate32,2M USD
    Operating incomeno estimateno estimate-2,2M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy0
    Hold1
    Sell0
    Strong sell0
    12-month price target$2,10 · Median $2,10
    Low $2,10High $2,10
    Operating income · consensus-2,2M USD
    EPS surprise
    −200,0 %
    reported vs consensus · miss
    Revenue surprise
    −5,9 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$2,10
    Mean$2,10
    Median$2,10
    High$2,10
    Spot$2,15
    −2.3 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-12,4 %Above median
    Net Margin-9,5 %Above median
    ROE-9,7 %Below median
    D/E0,00Above median
    Cash Conv-1,00Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Return On Equity
      net_income / total_equity
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    Source documents
    • Forian Inc. Market data — financials · 2026-05-27
    • Forian Inc. Market data — analyst estimates · 2026-05-27
    • Forian Inc. Market data — ESG · 2026-05-27

    Ownership & reference

    Top holders

    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$2M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M

    Insider activity

    — missing data

    Short positioning

    12.7Kshares short-76.2% vs prior
    1days to cover
    20.4Kfails-to-deliver
    as of 2026-05-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    FORA.OCanonical
    NASDAQ · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    • Net margin (FY 2025-12-31): -9.5%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.48xDerived (calculated)
    • Current ratio (FY 2025-12-31): 2.97xDerived (calculated)
    • Return on assets (FY 2025-12-31): -6.5%Derived (calculated)
    • Return on equity (FY 2025-12-31): -9.7%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 93.0%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 181.1%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 25.0%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 25.0%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 23.8%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 920.6%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 46.1%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): 101.9%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 50.1%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -0.9%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -6.4%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -16.2%Derived (calculated)
    • Net income (annual): USD -2.87MSEC XBRL filing
    • Shareholders' equity (annual): USD 29.78MSEC XBRL filing
    • Revenue (annual): USD 30.26MSEC XBRL filing
    • Pre-tax income (annual): USD -2.65MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Cash & equivalents (annual): USD 12.9MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage